48P Phase II trial on vaccination with autologous dendritic cells loaded with autologous tumour homogenate in resected glioblastoma (COMBI-GVAX): Clinical results of the first step. (December 2022) - Ridolfi, L.; Gurrieri, L.; Riva, M.N.; Bulgarelli, J.; Fausti, V.; F. de Rosa,; Guidoboni, M.; Foca, F.; Tazzari, M.; Petrini, M.; Granato, A.M.; Pancisi, E.; et al.